First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive
In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent
FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX
ACS Modifies Pap Test Guidelines
Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation
Comments Invited On Centers Program
Radiation Exposure Mostly Natural, NCRP Report Says
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power - Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
New NOFO aims to shrink applications by 40% - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Kevan Shokat made KRAS druggable. With daraxonrasib now in the clinic, he is “all in” on the ultimate target: p53
Shokat was named 2026 Stephenson Global Prize winner
